Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
INDIANAPOLIS, Dec. 19, 2017 -- PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, today announced that they are releasing PTS ConnectTM ScreenPro, a portable data capture software designed specifically for wellness screening professionals.
Unlike other portal systems, PTS ConnectTM ScreenPro does not require internet access and delivers a customized wellness report equipped with either a screener’s or customer’s logo. It’s equipped for use with PTS Diagnostics’ CardioChek® analyzers and is compatible with tablets and printers.
“Screeners want accurate and well-organized aggregate data reports so that they can make informed decisions about their wellness programs,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “ScreenPro’s printable, double-encrypted and HIPPAA-compliant reports can be instantly downloaded to USB or PC at the end of an event, allowing for a fast and efficient data analysis.”
Developed by StatBridge LLC and powered by the company’s Oxygen software, PTS ConnectTM ScreenPro is designed specifically for the professional screening market. This product is a multiple encrypted software and hardware solution for remote, non-Wi-Fi, and Wi-Fi enabled environments.
“We’re enthusiastic to partner with a leader in point-of-care diagnostics and optimistic that we’ll improve the field of population health, providing screening participants with accurate results that drive better wellness decisions,” said Peter Brew, CTO and Co-Founder of StatBridge LLC.
PTS Diagnostics will be rolling out PTS ConnectTM ScreenPro in the United States and abroad in the coming months. To learn more, reach out to a PTS Diagnostics’ area sales manager, email [email protected], or call 877-870-5610 (toll-free in the U.S.).
About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit ptsdiagnostics.com.
About StatBridge LLC:
StatBridge, LLC was born to bridge the gap between high tech point-of-care testing and low tech paper and pencil data collection systems which have been the industry standard. With the successful launch of OXYGEN, Health and Wellness screening companies have access to a state-of-the-art technology platform which provides intuitive operation, seamless client registration, elimination of transcription errors, and secure data collection and storage. Learn more at statbridge.com.
Press Contact:
Ryan Simpson, Marketing Associate
317-870-5610
[email protected]
